294 related articles for article (PubMed ID: 28891457)
1. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review.
Hofstraat SHI; Falla AM; Duffell EF; Hahné SJM; Amato-Gauci AJ; Veldhuijzen IK; Tavoschi L
Epidemiol Infect; 2017 Oct; 145(14):2873-2885. PubMed ID: 28891457
[TBL] [Abstract][Full Text] [Related]
2. Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries.
Falla AM; Ahmad AA; Duffell E; Noori T; Veldhuijzen IK
BMC Infect Dis; 2018 Jan; 18(1):42. PubMed ID: 29338702
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area.
Tavoschi L; Mason L; Petriti U; Bunge E; Veldhuijzen I; Duffell E
J Hosp Infect; 2019 Aug; 102(4):359-368. PubMed ID: 30885816
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update.
Han R; Zhou J; François C; Toumi M
BMC Infect Dis; 2019 Jul; 19(1):655. PubMed ID: 31337339
[TBL] [Abstract][Full Text] [Related]
5. Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review.
Bivegete S; McNaughton AL; Trickey A; Thornton Z; Scanlan B; Lim AG; Nerlander L; Fraser H; Walker JG; Hickman M; Vickerman P; Johnson H; Duffell E; Brooks-Pollock E; Christensen H
Euro Surveill; 2023 Jul; 28(30):. PubMed ID: 37498533
[TBL] [Abstract][Full Text] [Related]
6. Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling study.
Trickey A; Bivegete S; Duffell E; McNaughton AL; Nerlander L; Walker JG; Fraser H; Hickman M; Vickerman P; Brooks-Pollock E; Christensen H
BMC Infect Dis; 2023 Jul; 23(1):457. PubMed ID: 37430220
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review.
Mason LM; Duffell E; Veldhuijzen IK; Petriti U; Bunge EM; Tavoschi L
Euro Surveill; 2019 Jul; 24(30):. PubMed ID: 31362808
[TBL] [Abstract][Full Text] [Related]
9. Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016).
Aspinall EJ; Hutchinson SJ; Goldberg DJ; Valerio H; Mozalevskis A; Noori T; Duffell E; Tavoschi L
HIV Med; 2018 Feb; 19 Suppl 1():11-15. PubMed ID: 29488708
[TBL] [Abstract][Full Text] [Related]
10. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA - descriptive analysis and estimation of 2015 baseline.
Mårdh O; Quinten C; Amato-Gauci AJ; Duffell E
Infect Dis (Lond); 2020 Sep; 52(9):625-637. PubMed ID: 32644030
[No Abstract] [Full Text] [Related]
11. Prevalence of and risk factors for hepatitis B and C infection among Mongolian blood donors.
Tserenpuntsag B; Nelson K; Lamjav O; Triner W; Smith P; Kacica M; McNutt LA
Transfusion; 2010 Jan; 50(1):92-9. PubMed ID: 19788639
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.
Papa A; Felice C; Marzo M; Andrisani G; Armuzzi A; Covino M; Mocci G; Pugliese D; De Vitis I; Gasbarrini A; Rapaccini GL; Guidi L
J Crohns Colitis; 2013 Mar; 7(2):113-9. PubMed ID: 22464811
[TBL] [Abstract][Full Text] [Related]
13. Surveillance and epidemiology of hepatitis B and C in Europe - a review.
Rantala M; van de Laar MJ
Euro Surveill; 2008 May; 13(21):. PubMed ID: 18761967
[TBL] [Abstract][Full Text] [Related]
14. Healthcare-associated hepatitis B and C transmission to patients in the EU/EEA and UK: a systematic review of reported outbreaks between 2006 and 2021.
Singh J; Stoitsova S; Zakrzewska K; Henszel L; Rosińska M; Duffell E
BMC Public Health; 2022 Dec; 22(1):2260. PubMed ID: 36463162
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis B and C infections in the Netherlands: estimated prevalence in risk groups and the general population.
Koopsen J; van Steenbergen JE; Richardus JH; Prins M; Op de Coul ELM; Croes EA; Heil J; Zuure FR; Veldhuijzen IK
Epidemiol Infect; 2019 Jan; 147():e147. PubMed ID: 30869044
[TBL] [Abstract][Full Text] [Related]
16. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.
Hahné SJ; Veldhuijzen IK; Wiessing L; Lim TA; Salminen M; Laar Mv
BMC Infect Dis; 2013 Apr; 13():181. PubMed ID: 23597411
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review.
Carrillo-Santisteve P; Tavoschi L; Severi E; Bonfigli S; Edelstein M; Byström E; Lopalco P;
Lancet Infect Dis; 2017 Oct; 17(10):e306-e319. PubMed ID: 28645862
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinical spectrum of chronic viral hepatitis in a middle-aged Swedish general urban population.
Hoffmann G; Berglund G; Elmståhl S; Eriksson S; Verbaan H; Widell A; Lindgren S
Scand J Gastroenterol; 2000 Aug; 35(8):861-5. PubMed ID: 10994626
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis.
Agyeman AA; Ofori-Asenso R; Mprah A; Ashiagbor G
BMC Infect Dis; 2016 Aug; 16():391. PubMed ID: 27507267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
